Patents by Inventor Maria Duca

Maria Duca has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEOMYCIN BASED COMPOUNDS, AND PHARMACEUTICAL USE THEREOF
    Publication number: 20220395523
    Abstract: The present invention relates to the field of medicine, in particular of oncology. Especially, it provides new compounds useful in the treatment of various cancers, such as glioblastoma, colorectal or breast cancers. The present disclosure also relates to pharmaceutical compositions containing the disclosed compounds.
    Type: Application
    Filed: September 30, 2020
    Publication date: December 15, 2022
    Inventors: THIERRY VIROLLE, MARIA DUCA, DUC DUY VO, LAURENT TURCHI, HERVÉ CHNEIWEISS, MARIE-PIERRE JUNIER
  • Benzene sulfonamide thiazole compounds
    Patent number: 9567310
    Abstract: The present invention relates to compound of general formula (1) wherein R1 represents C6-C10 aryl comprising one or two fused rings, wherein from 2 to 5 carbon atoms may be replaced with a heteroatom selected from O, S and NR6, and eventually substituted with from 5 to 11 substituents selected from R6, halo, CN, NO2, CF3, OCF3, COOR6, OCOR6, SO2NR6R7, CONR6R7, NR6R7, NR6COR7, (CH2)p—NR6R7, (CH2)p—OR6 and (CH2)pSR6, as well as, if appropriate, their pharmaceutically acceptable salts and/or isomers, tautomers, solvates or isotopic variations thereof. The compounds are useful for the treatment of cancers.
    Type: Grant
    Filed: November 8, 2013
    Date of Patent: February 14, 2017
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHARCHE MEDICALE), UNIVERSITE NICE SOPHIA ANTIPOLIS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Stephane Rocchi, Robert Ballotti, Rachid Benhida, Michael Cerezo, Maria Duca, Jean-Patrick Joly
  • NEW BENZENE SULFONAMIDE THIAZOLE COMPOUNDS
    Publication number: 20150284347
    Abstract: The present invention relates to compound of general formula (1) wherein R1 represents C6-C10 aryl comprising one or two fused rings, wherein from 2 to 5 carbon atoms may be replaced with a heteroatom selected from O, S and NR6, and eventually substituted with from 5 to 11 substituents selected from R6, halo, CN, NO2, CF3, OCF3, COOR6, OCOR6, SO2NR6R7, CONR6R7, NR6R7, NR6COR7, (CH2)p—NR6R7, (CH2)p—OR6 and (CH2)pSR6, as well as, if appropriate, their pharmaceutically acceptable salts and/or isomers, tautomers, solvates or isotopic variations thereof. The compounds are useful for the treatment of cancers.
    Type: Application
    Filed: November 8, 2013
    Publication date: October 8, 2015
    Inventors: Stephane Rocchi, Robert Ballotti, Rachid Benhida, Michael Cerezo, Maria Duca, Jean-Patrick Joly